Copper-Based Metal-Organic Framework Impedes Triple-Negative Breast Cancer Metastasis via Local Estrogen Deprivation and Platelets Blockade

Metastasis is one of the main causes of failure in the treatment of triple-negative breast cancer (TNBC). Abnormally estrogen level and activated platelets are the key driving forces for TNBC metastasis. Here, an “ion/gas” bioactive nanogenerator (termed as IGBN), comprising a copper-based MOF and loaded cisplatin-arginine (Pt-Arg) prodrug, is developed for metastasis-promoting tumor microenvironment reprogramming and TNBC therapy. The copper-based MOF not only serves as a drug carrier, but also specifically produces Cu 2+ in tumors, which catalytic oxidizing estrogen to reduce estrogen levels in situ . Meanwhile, the rationally designed Pt-Arg prodrug reduced into cisplatin to significantly promote the generation of H 2 O 2 in the tumor, then permitting self-augmented cascade NO gas generation by oxidizing Arg through a H 2 O 2 self-supplied way, thus blocking platelet activation in tumor. We clarified that IGBN inhibited TNBC metastasis through local estrogen deprivation and platelets blockade, affording 88.4% inhibition of pulmonary metastasis in a 4T1 mammary adenocarcinoma model. Notably, the locally copper ion interference, NO gas therapy and cisplatin chemotherapy together resulted in an enhanced therapeutic efficacy in primary tumor ablation without significant toxicity. This “ion/gas” bioactive nanogenerator offers a robust and safe strategy for TNBC therapy.